<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Carey | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/hempgrass97/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/hempgrass97/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Carey.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">8934da86b6d8ab8213ad97d5de1a8979</guid>
				<title>Carey posted an update: noninferiority of a 25-μg dose of vaginal misoprostol every [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42411/</link>
				<pubDate>Sun, 09 Feb 2025 09:14:57 -0800</pubDate>

									<content:encoded><![CDATA[<p>noninferiority of a 25-μg dose of vaginal misoprostol every 4 hours to the dinoprostone pessary for cesarean delivery rates after induction of labor at term could not be demonstrated, although the confidence limit of the difference barely exceeded the noninferiority margin. Nonetheless, given the small difference between these cesarean delivery&hellip;<span class="activity-read-more" id="activity-read-more-42411"><a href="http://www.nationalboardinstitute.com/activity/p/42411/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a9e1820beb1ccbb27a03fb47c6212dca</guid>
				<title>Carey posted an update: recruited on February 14, 2021.







 ClinicalTrials.gov, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40610/</link>
				<pubDate>Fri, 07 Feb 2025 08:33:46 -0800</pubDate>

									<content:encoded><![CDATA[<p>recruited on February 14, 2021.</p>
<p> ClinicalTrials.gov, number NCT04403646 , registered on May 27th, 2020.</p>
<p> The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter&hellip;<span class="activity-read-more" id="activity-read-more-40610"><a href="http://www.nationalboardinstitute.com/activity/p/40610/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">02115eb80665f22efd3583254fb1df07</guid>
				<title>Carey posted an update: Microbial electrolysis cell (MEC) has excellent CH4 [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38873/</link>
				<pubDate>Wed, 05 Feb 2025 09:01:03 -0800</pubDate>

									<content:encoded><![CDATA[<p>Microbial electrolysis cell (MEC) has excellent CH4 production performance, however, CO2 still remains in the produced biogas at high content. For achieving in-situ CO2 sequestration and thus upgrading biogas, mineral carbonation was integrated into a MEC treating sludge hydrolysate. With 19 g/L wollastonite addition, in-situ mineral CO2&hellip;<span class="activity-read-more" id="activity-read-more-38873"><a href="http://www.nationalboardinstitute.com/activity/p/38873/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d70f47fe4f6e0c97e317e0db34cc4643</guid>
				<title>Carey posted an update: Vortioxetine hydrobromide is a common clinical medication [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37071/</link>
				<pubDate>Mon, 03 Feb 2025 08:54:25 -0800</pubDate>

									<content:encoded><![CDATA[<p>Vortioxetine hydrobromide is a common clinical medication for major depressive disorder (MDD). However, it remains unclear whether vortioxetine hydrobromide acts by affecting the structure and composition of gut microbiota. Here, we analyzed fecal samples from 28 healthy controls (HCs) and 26 patients with MDD before treatment with vortioxetine&hellip;<span class="activity-read-more" id="activity-read-more-37071"><a href="http://www.nationalboardinstitute.com/activity/p/37071/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c9e97b7eb459ffacc32296c4efae2da9</guid>
				<title>Carey posted an update: When deciding on an online purchase, consumers often face a [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34491/</link>
				<pubDate>Fri, 31 Jan 2025 09:11:53 -0800</pubDate>

									<content:encoded><![CDATA[<p>When deciding on an online purchase, consumers often face a plethora of information. <a href="https://www.selleckchem.com/products/10-dab-10-deacetylbaccatin.html" rel="nofollow ugc">learn more</a> Yet, individuals consumers differ greatly in the amount of information they are willing and able to acquire and process before making purchasing decisions. Extensively processing all available information does not necessarily promote good decisions.&hellip;<span class="activity-read-more" id="activity-read-more-34491"><a href="http://www.nationalboardinstitute.com/activity/p/34491/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a0cbd42b203a211aa34d8e6255e1266b</guid>
				<title>Carey posted an update: Radiotherapy, as well as chemotherapy and surgery, occupies [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/26796/</link>
				<pubDate>Tue, 28 Jan 2025 08:27:49 -0800</pubDate>

									<content:encoded><![CDATA[<p>Radiotherapy, as well as chemotherapy and surgery, occupies an essential position in tumor treatment. Nonetheless, insufficient radiation deposition and hypoxia-related radioresistance of cancer cells still are serious challenges in radiotherapy. Herein, we proposed a hollow PtCo nanosphere (PtCo NS)-based novel radiosensitizer with three&hellip;<span class="activity-read-more" id="activity-read-more-26796"><a href="http://www.nationalboardinstitute.com/activity/p/26796/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5f83b0f93dab9df9fc20e20fbafefd8e</guid>
				<title>Carey became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/26712/</link>
				<pubDate>Tue, 28 Jan 2025 08:22:16 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>